Cork, Ireland – Nov 4, 2010 – Radisens Diagnostics today won the Munster Regional Finals of the All-Island Seedcorn Business Competition and launched it’s BES Funding round for private investors. The business will present at the all Ireland finals in Dublin on 26th November, competing against 3 other regional winners for the top prize of €100,000.

Now in its eighth year, the prize fund for this year’s Seedcorn competition run by IntertradeIreland is €280,000. Through Seedcorn, companies on the island of Ireland have already leveraged approximately €125 million worth of additional equity investment.

Commenting on the win, Jerry O’Brien, CEO said “We are delighted to have been selected to represent Munster in the upcoming Seedcorn Competition Finals. To be judged by such a distinguished panel of business experts greatly validates our business proposition as we commercially deploy our innovative diagnostic platforms and push forward to take Radisens to the next level. Private investors can avail of a unique investment opportunity by requesting a BES Information Memorandum on our website”

About Radisens Diagnostics
Radisens Diagnostics develops disruptive point-of-care diagnostic platforms and multiplexed test panels, which diagnose and monitor patients for multiple chronic and acute care conditions. This is the only point-of-care platform to integrate immunoassay, biochemistry and cellular haematology onto a single test panel. Using a finger-prick of blood, the analyser returns laboratory-grade results in the doctor’s office within minutes. Radisens Diagnostics is a convergence of medical diagnostics and consumer electronics using disruptive patent pending technology to deliver on the significant market and clinical need for decentralising diagnostics into point of care settings such as doctor’s offices, outpatient and emergency room departments, intensive care units and hospital bedsides.

Commercial Contact:
E: info @ radisens.com
T: +353 21 4868190 / Fax: +353 21 4928909